Condition: Breast Cancer · Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
The primary objective of this study is to describe the percentage of patients with HER2-positive and Triple Negative tumour underwent neoadjuvant treatment in clinical practice during the past 5 years out of total number of patients who underwent neoadjuvant treatment, regardless molecular subtypes. Secondary objectives The secondary objectives which are limited to molecular subtypes of study interest, HER2-positive and Triple Negative tumours, are follow reported: * To perform a descriptive analysis on neoadjuvant treatment choice according to molecular subtype and initial staging; * To perform a descriptive analysis on clinical and tumour pathological characteristics according to molecular subtypes and initial staging; * To perform radiological response descriptive analysis achieved with neoadjuvant therapy according to treatment and instrumental examination type (for example: breast MRI, breast ultrasound or mammography); * To perform a descriptive analysis of surgical procedures for both, the breast and the axilla, according to radiological tumour response, initial staging and molecular subtypes; * To perform a descriptive analysis on therapies performed in adjuvant setting according to neoadjuvant treatment type, initial staging and molecular subtypes; * To describe and to analyse the eligibility criteria evolution in neoadjuvant treatment setting during the last 5 years; * To perform a descriptive analysis on pathological complete response (cPR) according to neoadjuvan…
This description comes directly from the study's public registry record.
Alessandra Fabi, MD · 0630157337 · alessandra.fabi@policlinicogemelli.it
Always discuss trial participation with your own doctor first.
| IRCCS - Centro di Riferimento Oncologico (C.R.O.) di Aviano | Aviano, PN, Italy | Active Not Recruiting |
| AOU Ospedali Riuniti Torrette di Ancona | Ancona, Italy | Not Yet Recruiting |
| A.O.R.N. "San Giuseppe Moscati" | Avellino, Italy | Recruiting |
| Presidio di Brindisi Di Summa - Perrino | Brindisi, Italy | Not Yet Recruiting |
| Humanitas Istituto Clinico Catanese | Catania, Italy | Not Yet Recruiting |
| Azienda Ospedaliera Universitaria "San Martino" - Istituto Nazionale per la Ricerca sul Cancro | Genova, Italy | Not Yet Recruiting |
| ASST - Azienda Ospedaliera Carlo Poma di Mantova | Mantua, Italy | Recruiting |
| Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRST S.r.l. | Meldola, Italy | Recruiting |
| Istituto Europeo di Oncologia | Milan, Italy | Not Yet Recruiting |
| ASST - Ospedale Sacco | Milan, Italy | Not Yet Recruiting |
| Azienda Ospedaliera Universitaria - P.O. di Modena | Modena, Italy | Not Yet Recruiting |
| Azienda Ospedaliera "A. Cardarelli" | Naples, Italy | Active Not Recruiting |
+ 17 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06894173